Panel Discussion: Reframing Muscarinic Modulation: Lessons from Trials, Selectivity Challenges & the Placebo Puzzle
Time: 10:00 am
day: Day One
Details:
- Explore real-world clinical trial insights, including implications of placebo response and operational variability on muscarinic agent outcomes.
- Discuss the evolving understanding of M1 vs. M4 receptor agonism and their roles in achieving therapeutic efficacy in schizophrenia.
